Regulation of stem cell fate in hematopoietic development

Journal of the Medical Association of Thailand

Volumn 89, Issue 10, 2006, Pages 1788-1797

  Leeanansaksiri, Wilairat ^a   Dechsukhum, Chavaboon ^b  

^a SURANAREE UNIVERSITY OF TECHNOLOGY   (Thailand)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Embryonic stem cell; Hematopoietic stem cell; Id transcription factor; Id1; Stem cell fate regulation

Indexed keywords

DNA BINDING PROTEIN; HEMOPOIETIC GROWTH FACTOR; TRANSCRIPTION FACTOR;

B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MYELOID PROGENITOR CELL; NONHUMAN; REVIEW;

ADULT STEM CELLS; EMBRYONIC STEM CELLS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS;

EID: 33751004730     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Spangrude G J, Smith L, Uchida N, Ikuta K, Heimfeld S, Friedman J, et al. Mouse hematopoietic stem cells. Blood 1991; 78: 1395-402.
2. Morrison SJ, Uchida N, Weissman IL. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol 1995; 1: 35-71.
3. Kondo MA, Wagers J, Manz MG, Prohaska SS, Scherer DC, Beilhack GF, et al. Biology of hematopoietic stem cells and progenitors: Implications for Clinical Application. Annu Rev Immunol 2003; 21: 759-806.
4. Zhang DE, Hohaus S, Voso MT, Chen HM, Smith LT, Hetherington CJ, et al. Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. Curr Top Microbiol Immunol 1996; 211: 137-47.
5. Tenen DG, Hromas R, Licht JD, Zhang DE. Transcription factors, normal myeloid development, and leukemia. Blood 1997; 90: 489-519.
6. Ward AC, Loeb DM, Soede-Bobok A, Touw IP, Friedman AD. Regulation of granulopoiesis by transcription factors and cytokine signals. Leukemia 2000; 14: 973-90.
7. Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer 2003; 3: 89-101.
8. Nagamura-Inoue T, Tamura T, Ozato K. Transcription factors that regulate growth and differentiation of myeloid cells. Int Rev Immunol 2001; 20: 83-105.
9. Zhu J, Emerson SG. 2002. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 2002; 21: 3295-313.
10. Lecuyer E, Hoang T. SCL: from the origin of hematopoiesis to stem cells and leukemia. Exp Hematol 2004; 32: 11-24.
11. Downing JR. The core-binding factor leukemias: lessons learned from murine models. Curr Opin Genet Dev 2003;13:48-54.
12. Kelly LM, Gilliland, DG. Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 2002; 3: 179-98.
13. Krug UA, Ganser A,Koeffler HP. Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene 2002; 21: 3475-95.
14. Lin RJ, Sternsdorf T, Tini M, Evans RM. Transcriptional regulation in acute promyelocytic leukemia. Oncogene 2001; 20: 7204-15.
15. Lorsbach RB, Downing JR. The role of the AML1 transcription factor in leukemogenesis. Int J Hematol 2001; 74: 258-65.
16. Scandura JM, Boccuni P, Cammenga J, Nimer SD. Transcription factor fusions in acute leukemia: variations on a theme. Oncogene 2002; 21: 3422-44.
17. Ephrussi A, Church GM. Tonegawa S, Gilbert W. B lineage - specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 1985; 227: 134-40.
18. Kiledjian M, Su LK, Kadesch T. Identification and characterization of two functional domains within the murine heavy-chain enhancer. Mol Cell Biol 1988; 8: 145-52.
19. Lassar AB, Buskin JN, Lockshon D, Davis RL, Apone S, Hauschka SD, et al. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 1989; 58: 823-31.
20. Tietze K, Oellers N, Knust E. Enhancer of splitD, a dominant mutation of Drosophila, and its use in the study of functional domains of a helix-loop-helix protein. Proc Natl Acad Sci USA 1992; 89: 6152-6.
21. Cooper CL, Brady G, Bilia F, Iscove NN, Quesenberry PJ. Expression of the Id family helix-loop-helix regulators during growth and development in the hematopoietic system. Blood1997; 89: 3155-65.
22. Weiler SR, Gooya JM, Ortiz M, Tsai S, Collins SJ, Keller JR. D3: a gene induced during myeloid cell differentiation of Linlo c-Kit+ Sca-1(+) progenitor cells. Blood 1999; 93: 527-36.
23. Zebedee Z, Hara E. Id proteins in cell cycle control and cellular senescence. Oncogene 2001; 20: 8317-25.
24. Benezra R, Rafii S, Lyden D. The Id proteins and angiogenesis. Oncogene 2001; 20: 8334-41.
25. Andres-Barquin PJ, Hernandez MC, Israel MA. Id genes in nervous system development. Histol Histopathol 2000; 15: 603-18.
26. Coppe JP, Smith AP, Desprez PY. Id proteins in epithelial cells. Exp Cell Res 2003; 285: 131-45.
27. Tzeng SF. Inhibitors of DNA binding in neural cell proliferation and differentiation. Neurochem Res 2003; 28: 45-52.
28. Yokota Y. Id and development. Oncogene 2001; 20: 8290-8.
29. Engel I, Murre C. The function of E- and Id proteins in lymphocyte development. Nat Rev Immunol 2001; 1: 193-9.
30. Massari ME, Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol 2000; 20: 429-40.
31. Kreider BL, Benezra R, Rovera G, Kadesch T. Inhibition of myeloid differentiation by the helix-loop-helix protein Id. Science 1992; 255: 1700-2.
32. Nogueria MT, Mitjavila-Garcia F, Le pesteur MD, Filippi W, Vainchenker A, Kupperschmitt, et al. Regulation of Id gene expression during embryonic stem cell-derived hematopoietic differentiation. Biochem Biophy Res Com 2000; 276: 803-12.
33. Leeanansaksiri W, Wang H, Gooya JM, Renn K, Abshari M, Tsai S, et al. IL-3 induces inhibitor of DNA-binding protein-1 in hematopoietic progenitor cells and promotes myeloid cell development. J Immunol 2005; 174: 7014-21.
34. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984; 81: 1991-5.
35. Hasskarl J, Munger K. Id proteins - tumor markers or oncogenes? Cancer Biol Ther 2002; 1: 91-6.
36. Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM. Id proteins in cell growth and tumorigenesis. Cancer Cell 2003; 3: 525-30.
37. Yokota Y, Mori S. Role of Id family proteins in growth control. J Cell Physiol 2002; 190: 21-8.
38. Tsai S, Collins SJ. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 1993; 90: 7153-57.
39. Tsai S, Bartelmez S, Sitnicka E, Collins S. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 1994; 8: 2831-41.
40. Georgopoulos K. Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol 2002; 2: 162-74.
41. Sun XH. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 1994; 79: 893-900.
42. Hirayama F, Ogawa M. Negative regulation of early T lymphopoiesis by interleukin-3 and interleukin-1 alpha. Blood 1995;86:4527-31.
43. Hirayama F, Clark SC, Ogawa M. Negative regulation of early B lymphopoiesis by interleukin 3 and interleukin 1 alpha. Proc Natl Acad Sci USA 1994; 91: 469-73.
44. Matsunaga T, Hirayama F, Yonemura Y, Murray R, Ogawa M. Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: transduction of the negative signals by betac and betaIL-3 proteins of IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor. Blood 1998; 92: 901-7.